6533b871fe1ef96bd12d0f1a
RESEARCH PRODUCT
Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma
Andreas HoetkerOguz AkinAna M. MolinaChung-han LeeRobert J. MotzerJane HouldsworthSujata PatilTheresa Margaret GoldBanumathy Gowrishankarsubject
Cancer ResearchSunitinibbusiness.industryChromosomeDiseaseurologic and male genital diseasesmedicine.diseaseClear cell renal cell carcinomaOncologyRenal cell carcinomamedicineCancer researchIn patientbusinessmedicine.drugdescription
4552 Background: Sunitinib is a 1st-line therapy for clear cell Renal Cell Carcinoma (ccRCC); however, 20-30% of tumors show primary resistant disease (PRD) with progression as the best response. T...
year | journal | country | edition | language |
---|---|---|---|---|
2015-05-20 |